• Open Access

Is there a genetic variation association in the IL-10 and TNF α promoter gene with gestational diabetes mellitus?

Authors

  • Shabnam Montazeri,

    1. Department of Obstetrics and Gynecology, Faculty of Medicine and Health, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, Malaysia
    Search for more papers by this author
  • Sivalingam Nalliah,

    1. Department of Obstetrics and Gynecology, Faculty of Medicine and Health, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, Malaysia
    Search for more papers by this author
  • Ammu Kutty Radhakrishnan

    1. Department of Obstetrics and Gynecology, Faculty of Medicine and Health, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, Malaysia
    Search for more papers by this author

Shabnam Montazeri, Faculty of Medicine and Health, International Medical University (IMU), 126, Jalan 19/155B, Bukit Jalil, 57000 Kuala Lumpur, Malaysia. E-mail: shabnam_montazeri@yahoo.com

Abstract

Gestational diabetes mellitus (GDM), defined as carbohydrate intolerance diagnosed for the first time during pregnancy, affects both maternal and fetal health. Possession of a specific genetic polymorphism can be a predisposing factor for susceptibility to some diseases. The aim of this study was to investigate the association between single nucleotide polymorphisms (SNP) in the promoter gene of interleukin-10 (IL-10) as well as tumor necrosis factor-alpha (TNF α) with the development of GDM.

Two hundred and twelve consecutive series of eligible normal pregnant women (controls) and gestational diabetes mellitus women were selected based on the study's inclusion and exclusion criteria.

DNA was extracted from blood and genotyped for IL-10 at three positions and TNF α for gene polymorphism using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Plasma levels of IL-10 and TNF α at different gestational periods as well as postpartum were quantified using enzyme linked immunosorbent assay (ELISA).

The results of the study showed that the difference in the frequency of SNP at position −597 in the promoter of the human IL-10 gene between the control and GDM groups was statistically significant (p < 0.05). In contrast, there was no significant difference in the frequency of SNP at the other two sites in the promoter region of the human IL-10 gene (−824 and −1082) as well as position −308 in the promoter of the human TNF-α (p > 0.05). In addition, there was no significant difference between the two groups in terms of plasma levels of IL-10 as well as TNF α in different stages of pregnancy.

SNP at position −597 was significantly associated with the development of GDM and shows potential for use as a predictive marker for GDM.

Ancillary